ARCHIVES

NCI Largely Unaffected By NIH Translational Research Center

This article is from The Cancer Letter archive.

Vol. 37 No. 06 | February 11, 2011

Download PDF Visit The Full Archive

Related Articles

Zaltrap Receives Positive Opinion For European Market From CHMP

November 30, 2012

‘Dear Dr. Bick’: Letters Reflect Turmoil Over Conflict Of Interest

January 26, 1990

Beta Carotene Doesn’t Help, May Hurt, Two Trials Find

January 26, 1996

UT System Launches Probe of Submission Of Controversial MD Anderson Grant

June 8, 2012

SOCMA Asks Congress for Carcinogen Classification Probe

March 25, 1988

DCPC Board Okays Reissuance Of RFA for Chemoprevention Clinical Trials

May 20, 1988